This inventor holds 9 USPTO granted patents, plus 2 CIPO patents. Top assignee: American Cyanamid Company. Active years: 1990-1998.
Company Filing History:
Years Active: 1990-1998
Title: The Innovative Contributions of George A. Ellestad
Introduction
George A. Ellestad is a notable inventor based in Pearl River, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Ellestad has made strides in developing compounds that address critical health issues, particularly viral infections.
Latest Patents
Among his latest patents is the invention titled "Triazine containing anionic compounds useful as antiviral agents." This invention provides triazine ring containing anionic compounds, pharmaceutical compositions containing these compounds, and methods utilizing these compounds for treating viral infections, particularly infections by respiratory syncytial virus. The compounds have a general structure that includes pharmaceutically acceptable salts. Another significant patent is the "Process for preparing targeted forms of methyltrithio antitumor agents." This disclosure describes a method for constructing targeting agent drug conjugates from the family of methyltrithio antibacterial and antitumor agents.
Career Highlights
Ellestad has spent a considerable part of his career at American Cyanamid Company, where he has been able to apply his innovative ideas and research to develop new pharmaceutical solutions. His work has had a lasting impact on the industry, particularly in the area of antiviral and antitumor therapies.
Collaborations
Throughout his career, Ellestad has collaborated with several esteemed colleagues, including William J. McGahren and Martin L. Sassiver. These collaborations have further enhanced his research and development efforts, leading to groundbreaking advancements in pharmaceutical science.
Conclusion
George A. Ellestad's contributions to the field of pharmaceuticals through his innovative patents and collaborations have made a significant impact on the treatment of viral infections and cancer. His work continues to inspire future innovations in the industry.